Table 3.
Baseline body weight (kg) |
Follow-up(months unless otherwise stated) |
Follow-up body weight (change in kg) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Int |
Control |
Int |
Control |
|||||||
M | SD | M | SD | M | SD | M | SD | Effect size (d) | ||
Mouttapa et al., 2011 | 71.7 | 17.43 | 74.91 | 21.42 | 6 weeks | ↓0.59 | 2.12 | ↓0.29 | 5.02 | –0.02 |
Tate et al., 2006 | CT = 89; HT = 89 | CT = 13.2; HT = 13 | 88.3 | 13.9 | 3, 6 | 3 months: CT = ↓5.3; HT = ↓6.16 months: CT = ↓4.9; HT = ↓7.3 | 3 months: CT = 4.2; HT = 3.9 months: CT = 5.9; HT = 6.2 | 3 months: ↓2.86 months: ↓2.6 | 3 months: 3.5; 6 months: 5.7 | 3 months:CT vs C = –0.19**; HT vs C = –0.26**; (no dif CT vs HT)6 months: CT vs C = –0.17; HT vs C = –.35***(HT>CT) |
van Genugten et al., 2012 | 83.39 | 11.49 | 83.34 | 10.61 | 1 (NR); 6 | ↓0.34 | 12.36 | ↓0.6 | 10.81 | 0.02 |
Godino et al., 2016 | 76.5 | 12.7^ | 76.5 | 13.2^ | 6, 12, 18, 24 | 6 months = ↓1.1; 12 months = ↓1; 18 months = ↓0.3; 24 months = ↑0.3 | NR | 6 months = ↑0.3; 12 months = ↑0.3; 18 months = ↑0.4; 24 months = ↑1.1 | NR | 6 months: –0.11*12 months: –0.1**18 months: –0.05 24 months: –0.06 |
Napolitano et al., 2013 | NR | NR | NR | NR | 1; 2 | 1 month = ↓1.72 months = ↓2.4 | 1 month = 1.6; 2 months = 2.5 | 1 month: AC = ↓0.46; C = ↑0.28; 2 months: AC = ↓0.63; C = ↓0.24 | 1 month:AC = 1.4; C = 1.72 months: AC = 2.4; C = 2.6 | ^^1 month: T vs AC = –0.5*; T vs C = –0.79***;2 months:T vs AC = –0.71*; T vs C = –0.86* |
Rothert et al., 2006 | 92.2 | 14.4 | 92.5 | 14.3 | 3; 6 | 3 months = ↓2.6; 6 months = ↓2.8 | NR | 3 months = ↓1.4; 6 months = ↓1.1 | NR | 3 months = –0.1***; 6 months = –0.12*** |
Note: ^raw standard deviation reported; ^^ follow-up SD used to calculate effect size; *p < 0.05 **p < 0.01, ***p < 0.001. CT = computer tailored; C = control; HT = human tailoring; T = tailored intervention; AC = active control; NR = not reported.